Tarsus Pharmaceuticals, Inc. · 5 months ago
Join Our Talent Community!
Irvine, California, United States
Full-time
Onsite
New Grad, Entry LevelTarsus Pharmaceuticals is a company that is experiencing major growth following the recent announcement of their Saturn-1 clinical trial results. They are inviting individuals to join their Talent Community for future job openings and encourage applicants to share their résumés for consideration.
BiopharmaBiotechnologyLife Science
Qualification
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Founded in 2017
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Jeffrey Farrow
Chief Financial Officer and Chief Strategy Officer
Bobak Azamian
Chairman
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase